North America Polynucleotides Injectables Market Size & Outlook

The polynucleotides injectables market in North America is expected to reach a projected revenue of US$ 24.6 million by 2030. A compound annual growth rate of 14.7% is expected of North America polynucleotides injectables market from 2025 to 2030.
Revenue, 2024 (US$M)
$11.1
Forecast, 2030 (US$M)
$24.6
CAGR, 2025 - 2030
14.7%
Report Coverage
North America

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

North America polynucleotides injectables market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

North America polynucleotides injectables market highlights

  • The North America polynucleotides injectables market generated a revenue of USD 11.1 million in 2024.
  • The market is expected to grow at a CAGR of 14.7% from 2025 to 2030.
  • In terms of segment, eyes was the largest revenue generating application in 2024.
  • Forehead is the most lucrative application segment registering the fastest growth during the forecast period.
  • Country-wise, U.S. is expected to register the highest CAGR from 2025 to 2030.

North America data book summary

Market revenue in 2024USD 11.1 million
Market revenue in 2030USD 24.6 million
Growth rate14.7% (CAGR from 2025 to 2030)
Largest segmentEyes
Fastest growing segmentForehead
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationEyes, Lips, Forehead, Jawline & Cheekbones
Key market players worldwideLG Chem, Pluryal, Pharma Research, Promoitalia, Bioplus Life Sciences, Mastelli

Other key industry trends

  • In terms of revenue, North America region accounted for 8.7% of the global polynucleotides injectables market in 2024.
  • Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 142.1 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Polynucleotides Injectables Market Companies

Name Profile # Employees HQ Website
Mastelli View profile 51-100 Imperia, Liguria, Italy, Europe https://www.mastelli.com/it/
Bioplus Life Sciences View profile 501-1000 Bengaluru, Karnataka, India, Asia http://www.bioplus.in/
Promoitalia View profile 11-50 Milano, Lombardia, Italy, Europe https://webpromoitalia.com
Pharma Research View profile 1-10 Guntur, Andhra Pradesh, India, Asia https://pharma-research.in/
Pluryal View profile 11-50 Luxembourg, Luxembourg, Luxembourg, Europe http://pluryal.com
LG Chem View profile 10001+ Seoul, Seoul-t'ukpyolsi, South Korea, Asia https://www.lgchem.com

North America polynucleotides injectables market size, by country, 2018-2030 (US$M)

North America Polynucleotides Injectables Market Outlook Share, 2024 & 2030 (US$M)

North America polynucleotides injectables market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online